Table 1 Qualitative description of the drug loss in deflated and inflated status.
Name | DCB deflated | DCB inflated | Class | |
|---|---|---|---|---|
Characteristics | Diameter (mm) | Characteristics | ||
Elutax 3 | No or hardly any abrasion of the drug/excipient | 1.20 | Clear abrasion of the drug/excipient | 1 |
Elutax SV Fistula | 1.34 | 1 | ||
In.Pact Admiral | 2.01 | 1 | ||
Luminor 35 | Clear abrasion of the drug/excipient | 1.94 | 2 | |
Lutonix 035 | No or hardly any abrasion of the drug/excipient | 1.98 | Drug shifted slightly, hardly any abrasion of the drug/excipient | 0 |
Ranger | Clear abrasion of the drug/excipient | 1.50 | Clear abrasion of the drug/excipient | 2 |
SeQuent Please OTW 35 | 1.92 | 2 | ||
Stellarex | Clear structure change inside, but no abrasion of drug/excipient | 1.96 | Drug shifted slightly, hardly any abrasion of the drug/excipient | 0 |